The knowledge of complex cellular–molecular mechanisms in PBMCs would allow the use of biomarkers such as HO-1, ADMA, Nrf2, and NF- kB for the assessment of imbalance in PBMCs in MetS. Here, HMOX1 is linked to metabolic syndrome.